Yahoo Web Search

  1. Yahoo Finance Results

  2. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.

  3. Eli Lilly And Co (NYSE: LLY) has become the latest company to have made a move in this direction. Less than e week after Bristol-Myers Squibb Co (NYSE: BMY) clinched ...

  4. Eli Lilly to Buy Loxo Oncology for $8 Billion

    Bloomberg via Yahoo FinanceJan 07 14:53 PM

    The purchase is Indianapolis-based Lilly’s biggest takeover ever, according to data compiled by Bloomberg. The Stamford, Connecticut-based biotechnology company is developing cancer treatments ...

  5. Why Eli Lilly Is Buying Loxo Oncology for $8 Billion

    Motley Fool via Yahoo FinanceJan 08 22:01 PM

    Eli Lilly and Co. (NYSE: LLY) is best known as the maker of top-selling diabetes medications, including the popular Humalog insulin, but it's also a big player in cancer ...

  6. Eli Lilly to spend about $8B on Loxo Oncology

    Associated Press via Yahoo FinanceJan 07 12:49 PM

    Eli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities. Loxo Oncology could ...

  7. Gilead, Pfizer Execs Suggest Even More Pharma M&A Is on Way

    Bloomberg via Yahoo FinanceJan 08 1:44 AM

    Eli Lilly & Co. said Monday it will acquire Loxo Oncology Inc. for about $8 billion in cash. The announcement came just days after Bristol-Myers Squibb Co. and Celgene ...

  8. Two Big Pharma Stocks Were Dow's Best, But 2019 Looks Shakier

    Bloomberg via Yahoo FinanceDec 31 14:22 PM

    On the broader S&P 500 Index, another big drug company, Eli Lilly & Co., was among the 20 largest gainers. Additionally, drug stocks that once seemed like bargains now look ...

  9. Eli Lilly (LLY.N) said on Monday it will buy Loxo Oncology Inc (LOXO.O) for $8 billion (£6.2 billion), an expensive bet on a pipeline of cancer drugs that target rare genetic mutations ...

  10. Lilly to buy Loxo Oncology for about $8 bln in cancer bet

    Reuters via Yahoo FinanceJan 07 11:47 AM

    Eli Lilly and Co said on Monday it would buy Loxo Oncology Inc for about $8 billion in cash, buying into a portfolio of targeted medicines to treat cancers caused by rare ...

  11. Adamis Pharmaceuticals Corp (NASDAQ: ADMP) announced its NDA filing Friday for a fast-dissolving sublingual tadalafil tablet for erectile dysfunction. Raymond James analyst Elliot Wilbur maintained ...